Tumor gene profiling is a tool that can help patients with a cancer diagnosis make informed decisions about treatment. In predominantly white populations, among men with early stage, favorable-risk prostate cancer, these tools have been shown to increase patient acceptance of active surveillance—a common, evidence-based approach to monitor the tumor before a more aggressive treatment, like surgery or radiation.
